In the present study, we found that ZNF217 expression at both mRNA and protein levels was significantly higher in colorectal tumor tissues than in its matched non-tumor tissues and its overexpression was associated with malignant clinicopathological features and short survival of CRC patients, indicating that ZNF217 functions as an oncogene in CRC. The gene discussed is ZNF217; the disease is colorectal neoplasm.